Developer docs
API playgroundTry for free, no card

Search company profiles

Everygene

Full company profile

uuid003k6so

Namestring
Everygene
Legal namestring
Everygene, PBC
Websiteurl
everygene.com
Company typeenum
Private
Founded yearint
2025
Descriptiontext

Everygene, PBC is a US-based Public Benefit Corporation that sells direct-to-consumer genetic health screening to health-conscious adults. Its sole commercial product, the Everygene Health Screen, is an at-home cheek-swab test that evaluates an 84-gene panel focused on medically actionable conditions. Customers receive results without a physician order, and positive findings include free genetic counseling.

The company outsources clinical laboratory processing to Mass General Brigham, an institutional partnership that supplies clinical-grade credibility typically unavailable to a 2024-founded DTC entrant. Results are delivered to consumers and include downloadable VCF files, giving customers portability of their raw genetic data. The product is positioned as a one-time purchase rather than a subscription, with pricing currently set at $199 per test after a reduction from the original $399 launch price.

Everygene operates a pure-play direct-to-consumer e-commerce model, with no disclosed enterprise, employer, payer, or health-system channels and no prescription requirement at point of sale. The PBC corporate structure aligns the entity's charter with public-benefit objectives around broader access to genetic information. The company is at an early operating stage: no funding rounds, management team, headcount, or revenue figures have been disclosed in the available material.

Short descriptiontext

Everygene is a US-based Public Benefit Corporation offering direct-to-consumer genetic health screening via an at-home cheek-swab test covering 84 medically actionable genes, with lab processing through Mass General Brigham and a one-time $199 price point.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
consumer genetic testing, at-home DNA kit, hereditary disease screening, preventive genetics service, medical actionable genes
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Consumer Genetic Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Genetic Health Screen Kit Sales
TypeOne Time License
Description

One-time purchase of at-home genetic screening kit. Customers pay upfront for the test, with no subscription or recurring fees. Positive test results include free 30-minute genetic counseling session.

everygene.com:443
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel
Pricing details1 tier
1Standard Health Screen - $199
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$199 per test (reduced from $399). Includes at-home cheek swab kit, analysis of 84 genes, downloadable genome file (.vcf), and free 30-minute genetic counseling if positive.

everygene.com:443
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Everygene is a direct-to-consumer genetic health screening company that sells a one-time at-home cheek swab test analyzing 84 genes linked to serious, medically actionable hereditary conditions. The sample is processed through a hospital-grade laboratory partnership with Mass General Brigham, with results returned directly to the consumer without requiring a physician order.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 3% detection rate identifies carriers of genes linked to preventable/treatable conditions among ~10 million Americans
Product overview1 text field

Everygene offers a single unified product: the Everygene Health Screen. This at-home genetic screening test analyzes 84 genes associated with treatable and preventable conditions, using a simple cheek swab methodology. Results are processed to hospital-grade standards in collaboration with Mass General Brigham. The product is priced at $199 (reduced from $399) and is designed as a one-time purchase with no subscription required, providing downloadable genome files (.vcf) and optional genetic counseling for positive results.

Product and service1 record
1Everygene Health Screen
CategoryConsumer Genetic Testing Services
Description

A one-time at-home genetic test sold directly to U.S. consumers that uses a cheek-swab sample to analyze 84 genes associated with serious, medically actionable hereditary conditions, with analysis performed by Mass General Brigham laboratories and results returned to the consumer without a prescription.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Mass General Brigham provides hospital-grade testing standards and clinical validation for Everygene's genetic health screen. Their lab processes samples and ensures results meet the same trusted standards used in major hospital systems. This partnership enables Everygene to offer clinical-quality genetic testing without requiring a prescription or hospital visit.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers8 records
TypeDirect peer
Description

MyHeritage offers DTC DNA testing for ancestry and health. Directly competes in the consumer genetic testing category with similar e-commerce distribution and at-home kit delivery model.

TypeDirect peer
Description

Color Health provides clinical-grade genetic testing focused on preventive health, hereditary cancer, and pharmacogenomics. Comparable medically-actionable gene panel approach with both DTC and employer channels.

TypeDirect peer
Description

23andMe is the dominant DTC genetic testing company offering health, ancestry, and trait reports. Directly competes with Everygene on the consumer-facing genetic health screen category, though with broader ancestry and wellness features.

TypeDirect peer
Description

Nebula Genomics offers whole genome sequencing directly to consumers with privacy-focused positioning. Comparable DTC whole-genome approach and downloadable data files (similar VCF delivery).

5Ancestry
TypeDirect peer
Description

Ancestry operates one of the largest DTC DNA testing services, primarily ancestry-focused but expanding into health. Comparable DTC distribution model and consumer brand awareness in the genetic testing space.

TypeEmerging player
Description

Helix operates a DNA testing platform serving both consumers and partners through an app-based marketplace. Comparable DTC distribution with broader ecosystem play and clinical lab infrastructure.

TypeBroad incumbent
Description

Invitae is a major clinical genetics company offering comprehensive genetic testing across multiple specialties. Provides overlapping test capabilities but primarily serves clinicians rather than DTC consumers.

TypeDirect peer
Description

Veritas Genetics provides whole genome sequencing with health interpretation, including medically actionable findings. Comparable DTC positioning with clinical-grade results and downloadable genome data.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Everygene

Consumer Genetic Testing Serviceseverygene.com

Everygene is a US-based Public Benefit Corporation offering direct-to-consumer genetic health screening via an at-home cheek-swab test covering 84 medically actionable genes, with lab processing through Mass General Brigham and a one-time $199 price point.

What Everygene does

Everygene, PBC is a US-based Public Benefit Corporation that sells direct-to-consumer genetic health screening to health-conscious adults. Its sole commercial product, the Everygene Health Screen, is an at-home cheek-swab test that evaluates an 84-gene panel focused on medically actionable conditions. Customers receive results without a physician order, and positive findings include free genetic counseling.

The company outsources clinical laboratory processing to Mass General Brigham, an institutional partnership that supplies clinical-grade credibility typically unavailable to a 2024-founded DTC entrant. Results are delivered to consumers and include downloadable VCF files, giving customers portability of their raw genetic data. The product is positioned as a one-time purchase rather than a subscription, with pricing currently set at $199 per test after a reduction from the original $399 launch price.

Everygene operates a pure-play direct-to-consumer e-commerce model, with no disclosed enterprise, employer, payer, or health-system channels and no prescription requirement at point of sale. The PBC corporate structure aligns the entity's charter with public-benefit objectives around broader access to genetic information. The company is at an early operating stage: no funding rounds, management team, headcount, or revenue figures have been disclosed in the available material.

Everygene firmographics

Firmographics
Name
Everygene
Legal name
Everygene, PBC
Website
https://everygene.com
Company type
Private
Founded year
2025
Operating status
Operating
Headcount range
1–10 employees
Short description
Everygene is a US-based Public Benefit Corporation offering direct-to-consumer genetic health screening via an at-home cheek-swab test covering 84 medically actionable genes, with lab processing through Mass General Brigham and a one-time $199 price point.
Ownership category
akta.pro rank

Everygene business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel

Revenue model

  1. Genetic Health Screen Kit Sales: One-time purchase of at-home genetic screening kit. Customers pay upfront for the test, with no subscription or recurring fees. Positive test results include free 30-minute genetic counseling session.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goStandard Health Screen - $199

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Everygene product offering

Product offering

Core offering

Everygene is a direct-to-consumer genetic health screening company that sells a one-time at-home cheek swab test analyzing 84 genes linked to serious, medically actionable hereditary conditions. The sample is processed through a hospital-grade laboratory partnership with Mass General Brigham, with results returned directly to the consumer without requiring a physician order.

Product overview

Everygene offers a single unified product: the Everygene Health Screen. This at-home genetic screening test analyzes 84 genes associated with treatable and preventable conditions, using a simple cheek swab methodology. Results are processed to hospital-grade standards in collaboration with Mass General Brigham. The product is priced at $199 (reduced from $399) and is designed as a one-time purchase with no subscription required, providing downloadable genome files (.vcf) and optional genetic counseling for positive results.

Differentiator

Problem solved

Functional benefit

Products and services

  • Everygene Health Screen A one-time at-home genetic test sold directly to U.S. consumers that uses a cheek-swab sample to analyze 84 genes associated with serious, medically actionable hereditary conditions, with analysis performed by Mass General Brigham laboratories and results returned to the consumer without a prescription.

Quantifiable outcome

  • 3% detection rate identifies carriers of genes linked to preventable/treatable conditions among ~10 million Americans

Companies that use Everygene

Customer profile

Segments2 records

Ideal customer profiles1 record

Everygene technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Everygene partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Mass General BrighamcoreStrategic or Co-development PartnerMass General Brigham provides hospital-grade testing standards and clinical validation for Everygene's genetic health screen. Their lab processes samples and ensures results meet the same trusted standards used in major hospital systems. This partnership enables Everygene to offer clinical-quality genetic testing without requiring a prescription or hospital visit.

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Everygene competitors and assessment

Company assessment

Direct peers

  • MyHeritage: MyHeritage offers DTC DNA testing for ancestry and health. Directly competes in the consumer genetic testing category with similar e-commerce distribution and at-home kit delivery model.
  • Color Health: Color Health provides clinical-grade genetic testing focused on preventive health, hereditary cancer, and pharmacogenomics. Comparable medically-actionable gene panel approach with both DTC and employer channels.
  • 23andMe: 23andMe is the dominant DTC genetic testing company offering health, ancestry, and trait reports. Directly competes with Everygene on the consumer-facing genetic health screen category, though with broader ancestry and wellness features.
  • Nebula Genomics: Nebula Genomics offers whole genome sequencing directly to consumers with privacy-focused positioning. Comparable DTC whole-genome approach and downloadable data files (similar VCF delivery).
  • Ancestry: Ancestry operates one of the largest DTC DNA testing services, primarily ancestry-focused but expanding into health. Comparable DTC distribution model and consumer brand awareness in the genetic testing space.
  • Veritas Genetics: Veritas Genetics provides whole genome sequencing with health interpretation, including medically actionable findings. Comparable DTC positioning with clinical-grade results and downloadable genome data.

Emerging players

  • Helix: Helix operates a DNA testing platform serving both consumers and partners through an app-based marketplace. Comparable DTC distribution with broader ecosystem play and clinical lab infrastructure.

Broad incumbents

  • Invitae: Invitae is a major clinical genetics company offering comprehensive genetic testing across multiple specialties. Provides overlapping test capabilities but primarily serves clinicians rather than DTC consumers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Everygene social profiles

Digital presence

Everygene financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Everygene leadership team

Management profile

Number of profiles

Profiles1 record

Everygene funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Everygene M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Everygene

What does Everygene do?

Everygene is a direct-to-consumer genetic health screening company that sells a one-time at-home cheek swab test analyzing 84 genes linked to serious, medically actionable hereditary conditions. The sample is processed through a hospital-grade laboratory partnership with Mass General Brigham, with results returned directly to the consumer without requiring a physician order.

Is Everygene a public or private company?

Everygene is a private company. It is classified as unknown and is currently operating.

When was Everygene founded?

Everygene was founded in 2025. It employs 1 to 10 people.

How does Everygene make money?

One revenue line is on record: genetic Health Screen Kit Sales.

Who are Everygene's main competitors?

Direct peers on record are MyHeritage, Color Health, 23andMe, Nebula Genomics, Ancestry and Veritas Genetics. Helix is listed as an emerging player. Invitae is listed as a broad incumbent.

Does Everygene have an API?

No public API is recorded for Everygene.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals